These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12962821)

  • 1. Effectiveness of low-dose intramuscular anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report.
    Alonso I; Herreros de Tejada A; Moreno JM; Rubio E; Lucena JL; De la Revilla J; Sánchez Turrión V; Gomez A; Lopez J; Cuervas-Mons V
    Transplant Proc; 2003 Aug; 35(5):1850-1. PubMed ID: 12962821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.
    Yao FY; Osorio RW; Roberts JP; Poordad FF; Briceno MN; Garcia-Kennedy R; Gish RR
    Liver Transpl Surg; 1999 Nov; 5(6):491-6. PubMed ID: 10545536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
    Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
    Stärkel P; Stoffel M; Lerut J; Horsmans Y
    Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.
    Rosenau J; Bahr MJ; Tillmann HL; Trautwein C; Klempnauer J; Manns MP; Böker KHW
    J Hepatol; 2001 Jun; 34(6):895-902. PubMed ID: 11451174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
    Rosenau J; Kreutz T; Kujawa M; Bahr MJ; Rifai K; Hooman N; Finger A; Michel G; Nashan B; Kuse ER; Klempnauer J; Tillmann HL; Manns MP
    J Hepatol; 2007 Apr; 46(4):635-44. PubMed ID: 17316869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.
    Karasu Z; Ozacar T; Akyildiz M; Demirbas T; Arikan C; Kobat A; Akarca U; Ersoz G; Gunsar F; Batur Y; Kilic M; Tokat Y
    Antivir Ther; 2004 Dec; 9(6):921-7. PubMed ID: 15651751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study.
    De Simone P; Romagnoli R; Tandoi F; Carrai P; Ercolani G; Peri E; Zamboni F; Mameli L; Di Benedetto F; Cillo U; De Carlis L; Lauterio A; Lupo L; Tisone G; Prieto M; Loinaz C; Mas A; Suddle A; Mutimer D; Roche B; Wartenberg-Demand A; Niemann G; Böhm H; Samuel D
    Transplantation; 2016 Jul; 100(7):1507-12. PubMed ID: 27023394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
    Angelico M; Di Paolo D; Trinito MO; Petrolati A; Araco A; Zazza S; Lionetti R; Casciani CU; Tisone G
    Hepatology; 2002 Jan; 35(1):176-81. PubMed ID: 11786974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation.
    Faust D; Rabenau HF; Allwinn R; Caspary WF; Zeuzem S
    Clin Transplant; 2003 Jun; 17(3):254-8. PubMed ID: 12780677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.
    Hooman N; Rifai K; Hadem J; Vaske B; Philipp G; Priess A; Klempnauer J; Tillmann HL; Manns MP; Rosenau J
    Liver Transpl; 2008 Apr; 14(4):435-42. PubMed ID: 18383078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
    Gane EJ; Angus PW; Strasser S; Crawford DH; Ring J; Jeffrey GP; McCaughan GW;
    Gastroenterology; 2007 Mar; 132(3):931-7. PubMed ID: 17383422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation.
    Adler R; Safadi R; Caraco Y; Rowe M; Etzioni A; Ashur Y; Shouval D
    Hepatology; 1999 Apr; 29(4):1299-305. PubMed ID: 10094978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation.
    Di Paolo D; Tisone G; Piccolo P; Lenci I; Zazza S; Angelico M
    Transplantation; 2004 Apr; 77(8):1203-8. PubMed ID: 15114086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
    Gane EJ; Patterson S; Strasser SI; McCaughan GW; Angus PW
    Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation.
    Karademir S; Astarcioğlu H; Akarsu M; Ozkardesler S; Ozzeybek D; Sayiner A; Akan M; Tankurt E; Astarcioğlu I
    Transplant Proc; 2006 Mar; 38(2):579-83. PubMed ID: 16549180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
    Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
    Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous administration of hepatitis B immune globulin in combination with lamivudine following orthotopic liver transplantation: effective prophylaxis against recurrence.
    Powell JJ; Apiratpracha W; Partovi N; Erb SR; Scudamore CH; Steinbrecher UP; Buczkowski AK; Chung SW; Yoshida EM
    Clin Transplant; 2006; 20(4):524-5. PubMed ID: 16842532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.